C. Nerl
C. Nerl publishes mostly in Genetics, Immunology and Hematology, on topics such as Chronic Lymphocytic Leukemia Research, Immunodeficiency and Autoimmune Disorders and Chronic Myeloid Leukemia Treatments.
- World rank
- #3,326,801 of 7,710,434 ranked researchers
- Rank in Germany
- #165,848 of 364,343
- Works
- 50
- Citations
- 1.2k
- Citations per work
- 24.9
What does C. Nerl research?
C. Nerl's work is mostly in Medicine (53%), Immunology and Microbiology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2753.2%
- Medicine2753.2%
- Everything else1632.4%
- Life Sciences714.4%
- 1Genetics19% of their works
- 2Immunology14% of their works
- 3Hematology13% of their works
- 4Pathology and Forensic Medicine9% of their works
- 5Rheumatology7% of their works
- 6Oncology6% of their works
Research topics
- Chronic Lymphocytic Leukemia Research
- Immunodeficiency and Autoimmune Disorders
- Chronic Myeloid Leukemia Treatments
- Lymphoma Diagnosis and Treatment
- Eosinophilic Disorders and Syndromes
- CNS Lymphoma Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Myeloid Leukemia Research
Which keywords describe C. Nerl's research?
The keywords of their largest research topics: Rituximab, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations, Classification, BCR-ABL, Genetic Mutations and Imatinib.
- Myelofibrosis
- Acute Myeloid Leukemia
- Primary CNS Lymphoma
- Prognostic Scoring System
- Fusion Genes
- Lymphoma
- Imatinib
- BCR-ABL
- Genomic Aberrations
- Prognostic Factors
- Rituximab
- Chronic Lymphocytic Leukemia
- Classification
- Genetic Mutations
- Primary Immunodeficiency
- Molecular Profiling
- Hypereosinophilic Syndrome
- Chemotherapy
- AML
- JAK2 Mutation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Rituximab332 topics
- Prognostic Factors252 topics
- Chronic Lymphocytic Leukemia221 topic
- Genomic Aberrations221 topic
- Classification182 topics
- BCR-ABL121 topic
- Genetic Mutations121 topic
- Imatinib121 topic
- Primary Immunodeficiency121 topic
- Lymphoma111 topic
- Molecular Profiling111 topic
- Fusion Genes71 topic
- Hypereosinophilic Syndrome71 topic
- Prognostic Scoring System72 topics
- Chemotherapy41 topic
- Primary CNS Lymphoma41 topic
- AML31 topic
- Acute Myeloid Leukemia31 topic
- JAK2 Mutation31 topic
- Myelofibrosis31 topic
Where does C. Nerl work?
C. Nerl's main affiliation in the publication record is München Klinik Schwabing, Germany.
How many publications and citations does C. Nerl have?
OpenAlex counts 50 works and 1,243 citations for C. Nerl, an h-index of 15, ranking #3,326,801 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about C. Nerl. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.